Atrium Therapeutics awards new hire stock options for 11,000 shares at $13.48 each
RNA•Inducement equity awards for new employee
Atrium Therapeutics issued inducement equity awards on Aug. 20, 2026 to one newly hired non-executive employee.
The grant included non-qualified stock options for 11,000 shares at an exercise price of $13.48 per share.
The options vest 25% after one year, then monthly over 36 installments, subject to continued service.
The award also included restricted stock units for 5,500 shares, vesting 25% after one year, then annually over three installments.
